Treatment Strategies in Primary Vitreoretinal Lymphoma A 17-Center European Collaborative Study

Tarih
2015
Yazar
SOBOLEWSKA, Bianka
BAARSMA, Seerp
HOYNG, Carel
CORDERO-COMA, Miguel
Tomkins-Netzer, Oren
ROZALSKI, Anna
Guex-Crosier, Yan
LOS, Leonoor I.
BOLLEMEIJER, Jan Geert
NOLAN, Andrew
PAWADE, Joya
Willermain, Francois
BODAGHI, Bahram
ten Dam-van Loon, Ninette
DICK, Andrew
ZIERHUT, Manfred
Lightman, Susan
MACKENSEN, Friederike
Moulin, Alexandre
Tugal-Tutkun, Ilknur
LE HOANG, Phuc
Erckens, Roel
MISSOTTEN, Tom
WENSING, Barbara
Lokhorst, Henk
ROTHOVA, Aniki
Riemens, Anjo
BROMBERG, Jacoline
TOUITOU, Valerie
Üst veri
Tüm öğe kaydını göster
Özet
IMPORTANCE The best treatment option for primary vitreoretinal lymphoma (PVRL) without signs of central nervous system lymphoma (CNSL) involvement determined on magnetic resonance imaging or in cerebrospinal fluid is unknown.
Bağlantı
http://hdl.handle.net/20.500.12627/65093
https://doi.org/10.1001/jamaophthalmol.2014.4755
Koleksiyonlar